PriceSensitive

Cannabix (CSE:BLO) develops version 4.0 of THC Breath Analyzer

Cannabis, Technology
CSE:BLO
01 February 2022 11:15 (EDT)

Source: Cannabix Technologies

Cannabix Technologies (BLO) has assembled its version 4.0 THC Breath Analyzer prototype and portable system for field use.

The THC Breath Analyzer (THCBA) is a drug screening device that provides a way for employers and law enforcement to quickly, easily, and non-invasively test for recent THC use.

Current forms of testing for marijuana use can identify THC ranging from minutes to days after actual use, making it impossible to show the difference between the two, remarked the company in its press release.

According to Cannabix, studies have shown that breath is a better indicator of impairment than saliva, blood, or urine because THC is present in breath for a relatively short period of time (1-3 hours) after consumption.

The Cannabix device allows for more relevant THC detection from breath, allowing employers to perform pre-access testing for recent use of marijuana before and during work hours.

The THCBA consists of a handheld device and protective case which houses a sterilization module, sample preparation stage, device recovery station and integrated battery charging system.

This updated version incorporates planned design changes and feedback from beta-test users. Changes include updating several components that will minimize manufacturing variability and reduce cost.

The company has commenced initial user testing and plans to begin broader field testing and clinical testing to establish benchmark standards for the 4.0 version of the device.

Cannabix Technologies Inc. is a developer of marijuana breathalyzer technologies for law enforcement and the workplace.

Shares in Cannabix Technologies (BLO) are up 12.90 per cent, trading at $0.70 per share as of 10:32 am EST.

Related News